Found 35 matching trials
Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
PHASE3This will be a multicenter, prospective, randomized, open-label trial with ...
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
PHASE2Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complicati...
Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms
PHASE2The goal of this clinical trial is to learn whether cabergoline can prevent...
Location
Maimonides Medical Center
Combination Osilodrostat and Cabergoline in Cushing's Disease
PHASE4Cushing disease remains a challenging endocrine disorder in which persisten...
Status
Enrolling By Invitation
Location
Faiha Specialized Diabetes, Endocrine, and Metabolism Center
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
PHASE2There are no available medical treatment options for patients with non-func...
Location
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss
PHASE2This research study investigates the use of a drug, cabergoline, given imme...
Location
Stanford University
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
NATo study the effects of rapid escalation of Cabergoline in comparison to co...
Location
Postgraduate Institute of Medical Education and Research
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
PHASE3This study was designed to check the efficacy of a new oral medical drug tr...
Location
Seth GSMC & KEM hospital
Cardiac Valve Complications in Prolactinomas Treated With Cabergoline
N/ADopamine agonists are first-line agents for the treatment of prolactinomas ...
Location
Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples
Clinical Guidance for Proper Treatment of Unexplained Resistant Hyperprolactinemia.
PHASE1Many women despite being well-treated in proper dose, with proper drug and ...
Location
Woman's Health University Hospital